About 150 industry officials, including venture capitalists and investors from large companies and mid-sized companies, attended the event, demonstrating the high interest in startups in the health industry.
Kwon Deok-cheol, president of the Korea Development Institute, said in his opening remarks, “As the health industry has great potential, we will do our best to support start-up companies. asked for
At the 5th K Big Star Day, ▲bioresorbable stent and coronary artery OCT (Dotter Inc.) ▲home smart oral diagnostic equipment (Smartus Korea) ▲antimicrobial resistance diagnosis technology and new inhibitor development (Dr. Pro Lab) ▲AI-based cardiovascular system Five companies, including disease diagnosis and treatment device (Medipixel) and human intestinal microbiome-based obesity treatment (Enterobiome), took part in the technology briefing.
In particular, clinical doctors such as Korea University Guro Hospital, Seoul Asan Hospital, Dongguk University Ilsan Hospital, and Korea University Anam Hospital participated and listened to the company announcement, provided an opportunity to develop the research direction by giving comments and advice as experts.
In addition, after the technology briefing session, a 1:1 meeting between startup companies and investment companies such as venture capital was prepared, and leading investment companies including large companies appeared, attracting attention.
Eom Bo-young, head of the Korea Health Industry Promotion Agency’s industry division, said, “The K-Big Star Day, prepared by the Health Industry Innovation Startup Center (KBIC), is receiving a lot of attention with each episode.”
